NanoGroup S.A. (WSE: NNG)

Poland flag Poland · Delayed Price · Currency is PLN
3.160
+0.050 (1.61%)
Jan 21, 2025, 9:47 AM CET
233.33%
Market Cap 88.03M
Revenue (ttm) 2.02K
Net Income (ttm) -6.86M
Shares Out 28.13M
EPS (ttm) -0.28
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 6,266
Average Volume 65,267
Open 3.140
Previous Close 3.110
Day's Range 3.030 - 3.160
52-Week Range 0.892 - 4.370
Beta 1.15
RSI 52.18
Earnings Date Apr 25, 2025

About NanoGroup

NanoGroup S.A. operates as a biotechnology company in Poland. The company develops and licenses early-stage pre-clinical and IND solutions to international biotech and pharma companies. It also manages a portfolio of companies that manages projects for the need of modern medicine in the field of oncology and transplantology. The company was incorporated in 2016 and is based in Warsaw, Poland. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2016
Country Poland
Stock Exchange Warsaw Stock Exchange
Ticker Symbol NNG
Full Company Profile

Financial Performance

In 2023, NanoGroup's revenue was 2,019, a decrease of -98.55% compared to the previous year's 139,549. Losses were -7.89 million, 840.8% more than in 2022.

Financial Statements

News

There is no news available yet.